• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 AI 米兰变体与心血管淀粉样变性的相关性研究

Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis.

机构信息

Division of Cardiology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA.

Tuscan Regional Amyloid Center, Careggi University Hospital, Florence, Italy.

出版信息

J Card Fail. 2022 Jun;28(6):950-959. doi: 10.1016/j.cardfail.2021.12.016. Epub 2021 Dec 30.

DOI:10.1016/j.cardfail.2021.12.016
PMID:34974181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9844506/
Abstract

BACKGROUND

The valine-to-isoleucine substitution (Val122Ile) is the most common variant of transthyretin (TTR) amyloidosis in the United States, affecting primarily individuals of African descent. This variant has been identified recently in a cluster of white individuals in Italy.

METHODS AND RESULTS

Clinical phenotype and chamber performance of Black and white individuals with Val122Ile TTR cardiac amyloidosis (ATTR-CA) were compared. Compared to white patients (n = 17), Black individuals (n = 53) had lower systolic blood pressures (110 vs 131 mmHg, <0.001), reduced pulse pressures (41 vs 58 mmHg; P < 0.001), and impaired renal function (eGFR 46 vs 67 mL/min/1.73m; P < 0.001) at presentation. Systolic properties and arterial elastance were similar. Black patients had end-diastolic pressure-volume relationships that were shifted upward and leftward relative to those of white patients, indicating reduced left ventricular chamber capacitance. Pressure-volume area at a left ventricular end-diastolic pressure of 30 mmHg was lower in Black than in white individuals (8055 mmHg/mL vs 11,538 mmHg/mL; P = 0.008).

CONCLUSION

Despite presenting at ages similar to those of white patients, Black individuals with Val122Ile-associated ATTR-CA had a greater degree of cardiac chamber dysfunction at the time of diagnosis due to impaired ventricular capacitance. Whether these differences are attributable to amyloidosis or other cardiovascular disease requires further study.

摘要

背景

缬氨酸到异亮氨酸取代(Val122Ile)是美国转甲状腺素蛋白(TTR)淀粉样变最常见的变体,主要影响非洲裔个体。最近在意大利的一个白人群体中发现了这种变体。

方法和结果

比较了 Val122Ile TTR 心脏淀粉样变(ATTR-CA)的黑人和白人个体的临床表型和房室性能。与白人患者(n=17)相比,黑人个体(n=53)的收缩压较低(110 对 131mmHg,<0.001),脉压较低(41 对 58mmHg;P<0.001),肾功能受损(eGFR 46 对 67mL/min/1.73m;P<0.001)。收缩期性能和动脉弹性相似。黑人患者的舒张末期压力-容积关系相对于白人患者向上和向左移位,表明左心室腔容量降低。左心室舒张末期压力为 30mmHg 时的压力-容积面积在黑人中低于白人(8055mmHg/mL 对 11538mmHg/mL;P=0.008)。

结论

尽管黑人患者与白人患者的发病年龄相似,但由于心室容量降低,黑人患者在诊断时存在更严重的心脏房室功能障碍。这些差异是归因于淀粉样变性还是其他心血管疾病,需要进一步研究。

相似文献

1
Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis.载脂蛋白 AI 米兰变体与心血管淀粉样变性的相关性研究
J Card Fail. 2022 Jun;28(6):950-959. doi: 10.1016/j.cardfail.2021.12.016. Epub 2021 Dec 30.
2
Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis Due to Val122Ile Mutation: Insights from Noninvasive Pressure-Volume Analysis.由于 Val122lle 突变导致转甲状腺素蛋白心脏淀粉样变的表型存在性别差异:来自无创压力-容积分析的见解。
J Card Fail. 2021 Jan;27(1):67-74. doi: 10.1016/j.cardfail.2020.08.007. Epub 2020 Aug 20.
3
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).转甲状腺素蛋白心脏淀粉样变性的基因型与表型:THAOS(转甲状腺素蛋白淀粉样变性结局调查)
J Am Coll Cardiol. 2016 Jul 12;68(2):161-72. doi: 10.1016/j.jacc.2016.03.596.
4
Relation of Body Mass Index to Transthyretin Cardiac Amyloidosis Particularly in Black and Hispanic Patients (from the SCAN-MP Study).体重指数与转甲状腺素蛋白心脏淀粉样变的关系,特别是在黑人和西班牙裔患者中(来自 SCAN-MP 研究)。
Am J Cardiol. 2022 Aug 15;177:116-120. doi: 10.1016/j.amjcard.2022.05.003. Epub 2022 Jun 12.
5
Design and Rationale the SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study.SCAN-MP(少数民族人群核医学心肌淀粉样变筛查研究)的设计和原理。
J Am Heart Assoc. 2023 Apr 18;12(8):e028534. doi: 10.1161/JAHA.122.028534. Epub 2023 Apr 17.
6
DISCOVERY: prevalence of transthyretin () mutations in a US-centric patient population suspected of having cardiac amyloidosis.发现:疑诊为心脏淀粉样变性的以美国为中心的患者人群中甲状腺素运载蛋白()突变的流行率。
Amyloid. 2020 Dec;27(4):223-230. doi: 10.1080/13506129.2020.1764928. Epub 2020 May 26.
7
Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.使用血清视黄醇结合蛋白 4 和临床预测模型鉴定转甲状腺素蛋白心脏淀粉样变性。
JAMA Cardiol. 2017 Mar 1;2(3):305-313. doi: 10.1001/jamacardio.2016.5864.
8
Counseling Family Members and Monitoring for Evidence of Disease in Asymptomatic Carriers of Amyloid Transthyretin Cardiac Amyloidosis.为转甲状腺素蛋白淀粉样变心肌病无症状携带者的家庭成员提供咨询并监测疾病证据
Am J Cardiol. 2022 Dec;185 Suppl 1:S43-S50. doi: 10.1016/j.amjcard.2022.09.011. Epub 2022 Oct 8.
9
Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals.载脂蛋白变异体 Val122lle 与黑人个体心力衰竭事件的相关性。
JAMA. 2022 Apr 12;327(14):1368-1378. doi: 10.1001/jama.2022.2896.
10
Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).转甲状腺素蛋白(ATTR)心脏淀粉样变性继发于 V122I 突变和野生型转甲状腺素蛋白的患者的压力-容积关系:转甲状腺素蛋白心脏淀粉样变性研究(TRACS)。
Circ Heart Fail. 2011 Mar;4(2):121-8. doi: 10.1161/CIRCHEARTFAILURE.109.910455. Epub 2010 Dec 29.

引用本文的文献

1
Clinical spectrum of Transthyretin amyloidogenic mutations among diverse population origins.不同人群来源的转甲状腺素蛋白淀粉样变性突变的临床谱。
Hum Genomics. 2024 Mar 25;18(1):31. doi: 10.1186/s40246-024-00596-7.
2
The ventilatory component of the muscle metaboreflex is overstimulated in transthyretin cardiac amyloidosis patients with poor aerobic capacity.在有氧能力较差的转甲状腺素蛋白心脏淀粉样变患者中,肌肉代谢反射的通气成分受到过度刺激。
Front Physiol. 2023 May 15;14:1174645. doi: 10.3389/fphys.2023.1174645. eCollection 2023.
3
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy.

本文引用的文献

1
Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis.利尿剂剂量和纽约心脏协会(NYHA)心功能分级是转甲状腺素蛋白心脏淀粉样变患者死亡率的独立预测因素。
JACC CardioOncol. 2020 Sep;2(3):414-424. doi: 10.1016/j.jaccao.2020.06.007. Epub 2020 Sep 15.
2
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.心脏淀粉样变性:不断发展的诊断和治疗——美国心脏协会的科学声明。
Circulation. 2020 Jul 7;142(1):e7-e22. doi: 10.1161/CIR.0000000000000792. Epub 2020 Jun 1.
3
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.
意大利中部致甲状腺素运载蛋白变异型 Val142Ile 高复发的研究。
Eur J Hum Genet. 2023 May;31(5):541-547. doi: 10.1038/s41431-022-01235-2. Epub 2022 Nov 15.
转甲状腺素蛋白淀粉样心肌病:美国心脏病学会最新临床综述
J Am Coll Cardiol. 2019 Jun 11;73(22):2872-2891. doi: 10.1016/j.jacc.2019.04.003.
4
Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS).西欧大陆的转甲状腺素蛋白心脏淀粉样变:通过转甲状腺素蛋白淀粉样变结局调查(THAOS)获得的见解
Eur Heart J. 2022 Feb 3;43(5):391-400. doi: 10.1093/eurheartj/ehz173.
5
Relation of the Myocardial Contraction Fraction, as Calculated from M-Mode Echocardiography, With Incident Heart Failure, Atherosclerotic Cardiovascular Disease and Mortality (Results from the Cardiovascular Health Study).基于M型超声心动图计算的心肌收缩分数与新发心力衰竭、动脉粥样硬化性心血管疾病及死亡率的关系(心血管健康研究结果)
Am J Cardiol. 2017 Mar 15;119(6):923-928. doi: 10.1016/j.amjcard.2016.11.048. Epub 2016 Dec 18.
6
Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC Study.负荷增加后左心室结构和功能重塑的种族差异:动脉粥样硬化风险社区研究(ARIC研究)
JACC Heart Fail. 2017 Mar;5(3):157-165. doi: 10.1016/j.jchf.2016.10.011. Epub 2016 Dec 21.
7
The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa.非洲淀粉样前体蛋白转甲状腺素(TTR)V122I等位基因的患病率及分布情况。
Mol Genet Genomic Med. 2016 Jul 14;4(5):548-56. doi: 10.1002/mgg3.231. eCollection 2016 Sep.
8
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).转甲状腺素蛋白心脏淀粉样变性的基因型与表型:THAOS(转甲状腺素蛋白淀粉样变性结局调查)
J Am Coll Cardiol. 2016 Jul 12;68(2):161-72. doi: 10.1016/j.jacc.2016.03.596.
9
The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience.缬氨酸142异亮氨酸转甲状腺素蛋白心脏淀粉样变性:不仅是一种非裔美国人的致病变异?一项意大利单中心经验。
J Cardiovasc Med (Hagerstown). 2016 Feb;17(2):122-5. doi: 10.2459/JCM.0000000000000290.
10
The amyloidogenic V122I transthyretin variant in elderly black Americans.老年美国黑人中的淀粉样变V122I转甲状腺素蛋白变体
N Engl J Med. 2015 Jan 1;372(1):21-9. doi: 10.1056/NEJMoa1404852.